Achieve Life Sciences (ACHV) is scheduled to announce Q1 earnings results on Tuesday, May 12th, before market open. The ...

Life sciences real estate is still under major pressure. Behind rows of unused microscopes, falling rents and anxious ...

Industry Leaders lists, an expansion of the TIME100 Most Influential Companies issue that dives deeper into 20 sectors to ...

Christopher Martin joins the Board of Directors, with Mark Zappia and Jim Willis joining as Senior Vice President of ...

The consensus estimate for Q1 2026 revenue is $10.44 million, and the earnings are expected to come in at -$0.16 per share. The full year 2026's revenue is expected to be $59.96 million and the ...

Grant program expands access to advanced single-domain antibody technologies to support the research and development of next-generation therapies ...

Life sciences executives are confronting a pivotal juncture in commercial strategy. The pharmaceutical and medical technology ...

Life sciences businesses are very healthy these days. Advances in research, testing, and manufacturing in the pharmaceutical, biotech, medical devices, and related industries continue to generate high ...

The life sciences industry is well positioned for growth in 2025, fueled by strong investor interest and technological advancements, especially in AI. Life sciences venture capital (VC) funding and ...

A ccording to the CBRE U.S. Life Sciences Outlook 2025 report, U.S life sciences employment hit a record high in 2024, and more job growth is expected in 2025. Meanwhile, the life sciences sector ...